Design, Synthesis, Evaluation and Computational Studies of Nipecotic Acid-Acetonaphthone Hybrids as Potential Antiepileptic Agents

2018 ◽  
Vol 14 (4) ◽  
pp. 409-426 ◽  
Author(s):  
Ankit Seth ◽  
Piyoosh A. Sharma ◽  
Avanish Tripathi ◽  
Priyanka K. Choubey ◽  
Pavan Srivastava ◽  
...  
Drug Research ◽  
2020 ◽  
Author(s):  
Meenakshi Dhanawat ◽  
Sumeet Gupta ◽  
Dinesh Kumar Mehta ◽  
Rina Das

Nipecotic acid is considered to be one of the most potent inhibitors of neuronal and glial-aminobutyric acid (GABA) uptake in vitro. Due to its hydrophilic nature, nipecotic acid does not readily cross the blood-brain barrier (BBB). Large neutral amino acids (LAT1)-knotted nipecotic acid prodrug was designed and synthesized with the aim to enhance the BBB permeation by the use of carrier-mediated transport. The synthesized prodrug was tested in animal models of Pentylenetetrazole (PTZ)-induced convulsions in mice. Further pain studies were carried out followed by neurotoxicity estimation by writhing and rota-rod test respectively. HPLC data suggests that the synthesized prodrug has improved penetration through BBB. Nipecotic acid-L-serine ester prodrug with considerable anti-epileptic activity, and the ability to permeate the BBB has been successfully synthesized. Graphical Abstract.


Molecules ◽  
2021 ◽  
Vol 26 (16) ◽  
pp. 4718
Author(s):  
Lamya H. Al-Wahaibi ◽  
Bahaa G. M. Youssif ◽  
Ehab S. Taher ◽  
Ahmed H. Abdelazeem ◽  
Antar A. Abdelhamid ◽  
...  

A novel series of tri-aryl imidazole derivatives 5a–n carrying benzene sulfonamide moiety has been designed for their selective inhibitory against hCA IX and XII activity. Six compounds were found to be potent and selective CA IX inhibitors with the order of 5g > 5b > 5d > 5e > 5g > 5n (Ki = 0.3–1.3 μM, and selectivity ratio for hCA IX over hCA XII = 5–12) relative to acetazolamide (Ki = 0.03 μM, and selectivity ratio for hCA IX over hCA XII = 0.20). The previous sixth inhibitors have been further investigated for their anti-proliferative activity against four different cancer cell lines using MTT assay. Compounds 5g and 5b demonstrated higher antiproliferative activity than other tested compounds (with GI50 = 2.3 and 2.8 M, respectively) in comparison to doxorubicin (GI50 = 1.1 M). Docking studies of these two compounds adopted orientation and binding interactions with a higher liability to enter the active side pocket CA-IX selectively similar to that of ligand 9FK. Molecular modelling simulation showed good agreement with the acquired biological evaluation.


2014 ◽  
Vol 444 ◽  
pp. 7-14 ◽  
Author(s):  
Elżbieta Bartoszak-Adamska ◽  
Zofia Dega-Szafran ◽  
Anna Komasa ◽  
Mirosław Szafran

2015 ◽  
pp. 911 ◽  
Author(s):  
Katharigatta Venugopala ◽  
Reshme Govender ◽  
Mohammed Khedr ◽  
Rashmi Venugopala ◽  
Bandar Aldhubiab ◽  
...  

2006 ◽  
Vol 128 (50) ◽  
pp. 16206-16212 ◽  
Author(s):  
Cheol-Min Park ◽  
Tetsuro Oie ◽  
Andrew M. Petros ◽  
Haichao Zhang ◽  
Paul M. Nimmer ◽  
...  

2015 ◽  
Vol 39 (5) ◽  
pp. 3777-3784 ◽  
Author(s):  
Arasappan Hemamalini ◽  
Sathish Kumar Mudedla ◽  
Venkatesan Subramanian ◽  
Thangamuthu Mohan Das

Ether-linked-bis-triazole derivatives have been synthesized by (CuAAC) “Click” reaction. Interaction of the compound with Hg2+has been demonstrated by various spectroscopic techniques which was further confirmed with computational studies.


2018 ◽  
Vol 55 (7) ◽  
pp. 1765-1774 ◽  
Author(s):  
Shivarudrappa H. Pattanashetty ◽  
K. M. Hosamani ◽  
Arun Kashivishwanath Shettar ◽  
R. Mohammed Shafeeulla

Sign in / Sign up

Export Citation Format

Share Document